medline.ch Onkologie

	RGS Family Remodeling in Breast Cancer: A Meta-Analysis and Multi-Omics Profiling of Prognostic Biomarkers. Cancer Med Mirzaei Z, Moghaddam MM, Barati T, Ebrahimi A, Khaniani MS. PMID: 42520291 [PubMed - as supplied by publisher]
	Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer. J Nucl Med Miller SR, Chung DH, Gonzalez RT, Jackson WC, Caram MEV, Tsao PA, Stensland K, Gulati R, Shah Y, Wale D, Elliott D, Caverly T, Hofer TP, Saini S, Green MD, Schipper M, Dess RT, Bryant AK. PMID: 42520266 [PubMed - as supplied by publisher]
	Stability and interpretability of penalized logistic regression models for breast cancer risk prediction. PLoS One Okyere F, Nyanney M. PMID: 42520065 [PubMed - as supplied by publisher]
	Factors affecting lung cancer stage at diagnosis and receipt of surgery in Ontario: A population-based analysis. PLoS One Hanna NM, Shakeel S, Akhtar-Danesh GG, Akhtar-Danesh N, Finley C. PMID: 42520043 [PubMed - as supplied by publisher]
	Piloting a Clinical Decision Support System for Unintended Weight Loss in Primary Care: Mixed Methods Study on Early Cancer Detection. JMIR Cancer Martinez-Gutierrez J, Chima S, Hunter B, Lee A, De Mendonca L, Daly D, Fishman G, Lim FS, Wang B, Nelson C, Nicholson B, Manski-Nankervis JA, Emery J. PMID: 42520031 [PubMed - as supplied by publisher]
	Realist Collaborative Evaluation of a Work Disability Prevention Program for Breast Cancer Survivors: Protocol for a RECOVA-FASTRACS Realist Evaluation. JMIR Res Protoc Blazer A, Rouat S, Guittard L, Drouin P, Péron J, Fervers B, Carretier J, Broc G, Letrilliart L, Fassier JB, Lamort-Bouché M. PMID: 42519964 [PubMed - as supplied by publisher]
	Correction: Impact of Hypertrophy-Oriented Resistance Training on Muscle Mass and Quality of Life in Patients with Unresectable Pancreatic Cancer (HY-PANC): Study Protocol for a Randomized Controlled Trial. Curr Protoc Braceras Arias P, Burgos Postigo S, B Alejo L. PMID: 42519871 [PubMed - as supplied by publisher]
	Early outcomes after focal high-dose-rate brachytherapy in low- and favorable intermediate-risk prostate cancer: promising early results from a prospective randomized trial. Open Med (Wars) Jonusas J, Patasius A, Trakymas M, Akelaitis K, Dziugelis M, Burkanas M, Venius J, Smailyte G, Kincius M. PMID: 42519814 [PubMed - as supplied by publisher]
	Artificial intelligence in three-dimensional total-body photography for skin cancer surveillance. Front Med (Lausanne) Lew KL, Sim KS, Chan WT. PMID: 42519779 [PubMed - as supplied by publisher]
	Research progress in metabolic reprogramming and targeting metabolic pathways for clear cell renal cell carcinoma. Genes Dis Yao JT, Hu PC, Li XW, Xu JC, Wang KJ, Ye SZ, Meng XY, Chen HC, Liang Y, Ma Q. PMID: 42519728 [PubMed - as supplied by publisher]
	Metagenome analysis reveals multi-kingdom gut microbiota as diagnostic markers for colorectal cancer. Front Microbiol Wang X, Wang J, Chen W, Sun J, Li J, Hu H. PMID: 42519695 [PubMed - as supplied by publisher]
	Associations between early changes in circulating tumor DNA (ctDNA) and outcomes across randomized trials: Insights from the ctMoniTR project. J Liq Biopsy Andrews HS, Zariffa N, Goren EM, Nishimura KK, Rosenthal A, Abukhdeir A, Collins G, Dajee M, Deng Y, Deng S, Ensor J, Espenschied CR, Fabrizio D, Guha M, Hodgson D, Juraeva D, Kräemer N, Leparc GG, Levi-D'Ancona E, Liu M, Merino Vega D, Navarro-Serer B, Pestano GA, Solovieff N, Sridhar S, Stewart MD, Sullivan JP, Wojciekowski S, Hoering A, Allen JD. PMID: 42519677 [PubMed - as supplied by publisher]
	Research advances on tumor-associated macrophages in pancreatic cancer. Biochem Biophys Rep Miao JY, Zhang LQ, He Y, Wang W. PMID: 42519576 [PubMed - as supplied by publisher]
	Clinical application of urinary NTx in patients with bone metastases from lung cancer. J Bone Oncol Jiang L, Zhang P, Wang Z, Chang X, Lu P, Zhang Y, Sang G. PMID: 42519555 [PubMed - as supplied by publisher]
	Real-world implementation of a pre-consultation patient educational tool for intermediate risk prostate cancer. Clin Transl Radiat Oncol Borras-Osorio M, Kowalchuk RO, Preston HR, Rajkumar AW, Uptmor AM, Davis BJ, Choo CR, Stish BJ, Phillips RM, Malouff TD, Traughber BJ, Wilson J, Lozko Y, Mastroleo F, Namazi MJ, Routman DM, Ebner DK, Waddle MR. PMID: 42519504 [PubMed - as supplied by publisher]
	Therapeutic repurposing of old drugs to modulate the tumor immune microenvironment and enhance immunotherapy efficacy. J Pharm Anal Song Y, Zheng N, Yang X, Tao Z, Wang Q, Cao Z, Zhang Y, Li M, Mao R, Chen Y, Zhao C, Yang H, Yang B, Ma Q, He L, Liu S, Li K. PMID: 42519351 [PubMed - as supplied by publisher]
	Neoadjuvant therapy for hepatocellular carcinoma: emerging combinations and biomarker challenges. Front Immunol Palihati S, Mo H, Ye X, Yi C, Liang X. PMID: 42519345 [PubMed - as supplied by publisher]
	Single-cell and spatial omics in non-small cell lung cancer: dissecting metabolic reprogramming and tumor-immune ecosystems for precision pharmacology. Front Immunol Lian Z, Wu XJ, Zhou Y, Tang P, Ge H. PMID: 42519324 [PubMed - as supplied by publisher]
	A comprehensive study based on large-sample multi-omics integration and machine learning to decode mitochondria-associated genes: from digestive tract tumours to gastric cancer. Front Immunol Zhang W, Tang YL, Chen YY, Shang Y, Mo HB, Huang J, Li YF, Liu ZH, Tan GL, Ning YK, Chen GQ, Ling JW, Wang L, Jiang JS, Luo JY, Chen G. PMID: 42519312 [PubMed - as supplied by publisher]
	Cytokine delivery and targeting strategies in pet dogs with cancer: a comparative immuno-oncology approach. Front Immunol Passos Barbosa MM, Fan TM. PMID: 42519309 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 1959144

Seite 1 von 97958

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung